GSK Files Colistin For Multidrug-Resistant P. aeruginosa In Japan
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline has recently filed for the approval of colistin methanesulfonate sodium, a cyclic polypeptide antibiotic, in the treatment of multidrug-resistant Pseudomonas aeruginosa infections.